Rankings
▼
Calendar
ALKS FY 2013 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
FY 2013 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$576M
+0.0% YoY
Gross Profit
$265M
46.1% margin
Operating Income
$82M
14.2% margin
Net Income
$25M
4.3% margin
EPS (Diluted)
$0.18
Cash Flow
Operating Cash Flow
$127M
Free Cash Flow
$104M
Stock-Based Comp.
$41M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$518M
Stockholders' Equity
$952M
Cash & Equivalents
$97M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$576M
$576M
+0.0%
Gross Profit
$265M
$405M
-34.6%
Operating Income
$82M
$82M
+0.0%
Net Income
$25M
$25M
+0.0%
← FY 2012
All Quarters
FY 2014 →